Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Aisporna
Maria Aisporna
Amylin Pharmaceuticals
Exenatide
Incretin
Medicine
Type 2 diabetes
Insulin
4
Papers
661
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.
2011
Clinical Pharmacokinectics
Mark Fineman
Shawn Flanagan
Kristin Taylor
Maria Aisporna
Larry Z. Shen
Kenneth F. Mace
Brandon Walsh
Michaela Diamant
Brenda Cirincione
Prajakti A. Kothare
Wen-I Li
Leigh MacConell
Show All
Source
Cite
Save
Citations (111)
Day-long Subcutaneous Infusion of Exenatide Lowers Glycemia in Patients with Type 2 Diabetes
2005
Hormone and Metabolic Research
Kristin Taylor
Dennis Kim
Loretta L. Nielsen
Maria Aisporna
Alain D. Baron
Mark Fineman
Show All
Source
Cite
Save
Citations (32)
Effect of injection site on relative bioavailability of exenatide (synthetic exendin‐4)
2004
Clinical Pharmacology & Therapeutics
F. Calara
Kristin Taylor
Jenny Han
Maria Aisporna
E. Zabala
E. Carr
Mark Fineman
Show All
Source
Cite
Save
Citations (2)
1